CDK17 KO cell lysate available now. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp insertion in exon 2.
Images
Key facts
- Cell type
- HeLa
- Species or organism
- Human
- Tissue
- Cervix
- Knockout validation
- Sanger Sequencing
- Mutation description
- Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp insertion in exon 2.
Alternative names
6430598J10Rik, CDK17_HUMAN, Cell division protein kinase 17, Cyclin-dependent kinase 17, EC 2.7.1.37, MGC25109, PCTAIRE-motif protein kinase 2, PCTK2, Protein kinase cdc2-related PCTAIRE-2, Serine/threonine-protein kinase PCTAIRE-2
What's included?
Recommended products
CDK17 KO cell lysate available now. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp insertion in exon 2.
Key facts
- Cell type
- HeLa
- Species or organism
- Human
- Tissue
- Cervix
- Knockout validation
- Sanger Sequencing
- Mutation description
- Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp insertion in exon 2.
- Disease
- Adenocarcinoma
- Concentration
Properties
- Gene name
- CDK17
- Gene editing type
- Knockout
- Gene editing method
- CRISPR technology
- Knockout validation
- Sanger Sequencing
Quality control
- STR analysis
- CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
- Biosafety level
- EU: 2 US: 2
- Adherent/suspension
- Adherent
- Gender
- Female
Storage
- Shipped at conditions
- Ambient - Can Ship with Ice
- Appropriate short-term storage conditions
- -20°C
- Appropriate long-term storage conditions
- -20°C
Notes
Knockout cell lysate achieved by CRISPR/Cas9.
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.
Supplementary info
- This supplementary information is collated from multiple sources and compiled automatically.
- Activity summary
PCTAIRE2 also known as cyclin-dependent kinase 17 (CDK17) belongs to the large kinase family specifically involved in cell cycle regulation. It has a molecular mass of approximately 57 kDa and is mainly expressed in the brain and testis tissues. Like other members of the CDK family PCTAIRE2's activity is regulated by the binding of cyclins but it displays distinct substrate specificities. This protein structure includes a conserved kinase domain that suggests its role in phosphorylation and signal transduction processes.
- Biological function summary
PCTAIRE2 functions in the modulation of neurodevelopmental processes and perhaps in the regulation of signal transmission in neurons. It may form complexes with various regulatory subunits affecting neuronal differentiation and outgrowth specifically in the brain. The presence of PCTAIRE2 in testis tissue indicates its potential role in reproductive biology though this function remains less understood compared to its neurological activities.
- Pathways
PCTAIRE2 participates actively in pathways linked to neuronal signaling and development. The phosphorylation activity of PCTAIRE2 intertwines with proteins such as cyclins enabling the progression and regulation of cellular cycles particularly within neuronal cells. Moreover PCTAIRE2 links to pathways that include synaptic signaling interacting with related kinases that impact neuron structure and function though specific relationships to direct pathway members remain under ongoing investigation.
- Associated diseases and disorders
Researchers associate PCTAIRE2 with neurodegenerative conditions like Alzheimer's disease given its significant role in the brain. Its dysregulation could affect neuronal signaling pathways potentially leading to cognitive deficits. Additionally abnormalities in PCTAIRE2 expression relate to disorders of the male reproductive system though the precise mechanisms require further elucidation. Its interaction with key proteins such as tau protein may uncover further insights about its role in disease pathology where tauopathy plays a part.
Product promise
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2 product images
Sanger Sequencing - Human CDK17 (PCTAIRE2) knockout HeLa cell lysate (ab263144)
Allele-1: 1 bp insertion in exon 2
Sanger Sequencing - Human CDK17 (PCTAIRE2) knockout HeLa cell lysate (ab263144)
Allele-2: 2 bp insertion in exon 2
Downloads
Product protocols
- Visit the general protocols
- Visit troubleshooting
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com